BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21254735)

  • 21. In vivo optical coherence tomography in assessment of suspicious facial lesions: A prospective study.
    Jerjes W; Hamdoon Z; Rashed D; Sattar AA; Hopper C
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102493. PubMed ID: 34419675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
    Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma based on in vivo analysis of optical properties by high-definition optical coherence tomography.
    Boone MA; Suppa M; Marneffe A; Miyamoto M; Jemec GB; Del Marmol V
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1714-1725. PubMed ID: 27311752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
    Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
    Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical coherence tomography in the diagnosis of actinic keratosis-A systematic review.
    Friis KBE; Themstrup L; Jemec GBE
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():98-104. PubMed ID: 28188920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Line-Field Confocal Optical Coherence Tomography for the Diagnosis of Skin Carcinomas: Real-Life Data over Three Years.
    Donelli C; Suppa M; Tognetti L; Perrot JL; Calabrese L; Pérez-Anker J; Malvehy J; Rubegni P; Cinotti E
    Curr Oncol; 2023 Sep; 30(10):8853-8864. PubMed ID: 37887539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical applicability of in vivo reflectance confocal microscopy in dermatology.
    Ulrich M; Lange-Asschenfeldt S; Gonzalez S
    G Ital Dermatol Venereol; 2012 Apr; 147(2):171-8. PubMed ID: 22481580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bowen's Disease in Dermoscopy.
    Wozniak-Rito AM; Rudnicka L
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):157-161. PubMed ID: 29989873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
    Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
    J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical coherence tomography in dermatology.
    Olsen J; Themstrup L; Jemec GB
    G Ital Dermatol Venereol; 2015 Oct; 150(5):603-15. PubMed ID: 26129683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Line-field confocal optical coherence tomography of basosquamous carcinoma: a case series with histopathological correlation.
    Cappilli S; Cinotti E; Lenoir C; Tognetti L; Perez-Anker J; Rubegni P; Puig S; Malvehy J; Perrot JL; Del Marmol V; Peris K; Suppa M
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1214-1218. PubMed ID: 35224784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a Combined Reflectance Confocal Microscopy-Optical Coherence Tomography Device for Detection and Depth Assessment of Basal Cell Carcinoma.
    Sahu A; Yélamos O; Iftimia N; Cordova M; Alessi-Fox C; Gill M; Maguluri G; Dusza SW; Navarrete-Dechent C; González S; Rossi AM; Marghoob AA; Rajadhyaksha M; Chen CJ
    JAMA Dermatol; 2018 Oct; 154(10):1175-1183. PubMed ID: 30140851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in optical coherence tomography].
    Ruini C; Daxenberger F; Gust C; Schuh S; French LE; Welzel J; Sattler EC
    Hautarzt; 2021 Dec; 72(12):1048-1057. PubMed ID: 34698874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIPK2 expression in progression of cutaneous epithelial neoplasm.
    Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
    Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Imaging of actinic porokeratosis by optical coherence tomography (OCT)].
    von Felbert V; Neis M; Megahed M; Spöler F
    Hautarzt; 2008 Nov; 59(11):877-9. PubMed ID: 18931984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin checks in primary care.
    Sinclair R; Meah N; Arasu A
    Aust J Gen Pract; 2019 Sep; 48(9):614-619. PubMed ID: 31476828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma.
    McArdle JP; Knight BA; Halliday GM; Muller HK; Rowden G
    Pathology; 1986 Apr; 18(2):212-6. PubMed ID: 3763243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo measurements of blood vessels' distribution in non-melanoma skin cancer by dynamic optical coherence tomography - a new quantitative measure?
    Sigsgaard V; Themstrup L; Theut Riis P; Olsen J; Jemec GB
    Skin Res Technol; 2018 Feb; 24(1):123-128. PubMed ID: 28771885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study.
    Boone MA; Norrenberg S; Jemec GB; Del Marmol V
    Exp Dermatol; 2013 Feb; 22(2):93-7. PubMed ID: 23301958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunct use of optical coherence tomography increases the detection of recurrent basal cell carcinoma over clinical and dermoscopic examination alone.
    Hussain AA; Themstrup L; Nürnberg BM; Jemec G
    Photodiagnosis Photodyn Ther; 2016 Jun; 14():178-84. PubMed ID: 27109055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.